News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No articles were published in the past hour across the provided news feed.
  • No market-moving economic releases appeared in the last hour.
  • No major geopolitical events or conflicts were reported in the past hour.
  • No corporate earnings, M&A, or material company announcements appeared this hour.
  • No central-bank statements or policy updates were released in the past hour.
  • Traders have no new headline catalysts from the past hour to change positioning.

Latest Articles

Slide Insurance Holdings, Inc. Initiates Quarterly Dividend

Slide Insurance Holdings, Inc. Initiates Quarterly Dividend

Slide Insurance Holdings, Inc. has declared its first quarterly dividend of $0.07 per common share, payable in August 2026. The board emphasized this move as a sign of confidence in their business fundamentals and balance sheet strength, while maintaining capital for long-term growth. The company is a technology-driven insurer leveraging AI for opt…

Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement

Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement

Scribe Therapeutics, a clinical-stage biotech company specializing in CRISPR-based genetic therapies targeting cardiometabolic diseases, has successfully closed an upsized IPO raising approximately $155.5 million. The offering included full exercise of underwriters' options and a concurrent private placement with Sanofi. The company aims to develop…

CBNK Reports 2Q ROA of 1.52% and EPS of $0.87

CBNK Reports 2Q ROA of 1.52% and EPS of $0.87

Capital Bancorp, Inc. (NASDAQ: CBNK) reported its second quarter 2026 results, showcasing a 1.52% return on assets and diluted earnings per share of $0.87, up 19% from the prior quarter. The company experienced robust growth in gross loans and deposits, enhanced tangible book value per share, and diversified fee income streams. Strategic investment…

HF Foods to Report Second Quarter 2026 Results on August 10, 2026

HF Foods to Report Second Quarter 2026 Results on August 10, 2026

HF Foods Group Inc., a leading distributor of international foodservice products primarily to Asian restaurants across the U.S., announced it will release its second quarter 2026 financial results on August 10, 2026, after market close. The company will host a conference call accessible via webcast to discuss the performance and outlook.

Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026

Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026

Denali Therapeutics announced the scheduled release of its second quarter 2026 financial results and business highlights on August 6, 2026. Management will hold a conference call and webcast to discuss these results and provide a general business update. Denali focuses on developing biotherapeutics capable of crossing the blood-brain barrier to tre…

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Carlsmed, Inc., a medical technology company specializing in AI-enabled personalized spine surgery solutions, announced its management team's participation in two upcoming virtual investor conferences in August 2026, including the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference and the Bank of America SMID Cap Virtual Conference. T…

ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease

ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease

ProMIS Neurosciences announced a webinar to discuss the six-month blinded interim safety data and biomarker trends from its Phase 1b PRECISE-AD trial evaluating PMN310, a monoclonal antibody targeting toxic amyloid-beta oligomers in early Alzheimer's disease patients. The trial assesses safety, tolerability, and pharmacokinetics with data from 144 …

American Express: Cash-Generative Moat Meets a Tactical Long Opportunity

American Express: Cash-Generative Moat Meets a Tactical Long Opportunity

American Express (AXP) combines a high-return, brand-driven payments franchise with strong free cash flow and durable fee economics. Recent Q2 beats on EPS, 15% fee revenue growth and a raised revenue guide argue for continued upside. Valuation is not cheap but looks reasonable vs. cash generation; technicals and reinvestment plans warrant a struct…

Tate Brothers Seek Bail as U.S. Courts Weigh Britain’s Extradition Request

Tate Brothers Seek Bail as U.S. Courts Weigh Britain’s Extradition Request

Andrew and Tristan Tate, detained in Miami since July 18, will file for bail and ask to be released from federal custody as U.S. courts consider a British request to extradite them on multiple charges including rape, assault and facilitating trafficking for sexual exploitation. British prosecutors have brought new charges and have until mid-Septemb…

U.S. Critical Minerals Push Faces Steep Capacity Gap Ahead of 2027 Ban

U.S. Critical Minerals Push Faces Steep Capacity Gap Ahead of 2027 Ban

Federal efforts to end reliance on certain foreign critical minerals by Jan. 1, 2027 are colliding with limited domestic production and processing capacity. Despite substantial government funding and new executive actions tightening waivers for defense contractors, U.S. miners and refiners remain far short of meeting projected demand for rare earth…